Abstract
The assessment of the ER-status requires surgical intervention. A non-invasive technique for simultaneous ER-detection in prime tumors and metastases is introduced with the use of the radiolabeled estrogen 16-alpha-I-123-Iodestradiol-17- in a study of 53 patients with suspected breast cancer. Although not yet available for routine use, this agent may provide information about the receptor density, heterogeneity or changes of ER-status during therapy.
| Translated title of the contribution | Estradiol I123 scintigraphy in breast carcinoma: Receptor assessment without biopsy? |
|---|---|
| Original language | German |
| Pages (from-to) | 1210-1216 |
| Number of pages | 7 |
| Journal | Therapiewoche |
| Volume | 42 |
| Issue number | 20 |
| State | Published - 1992 |
| Externally published | Yes |
